Michael J. Poitras

Dana-Farber Cancer Institute

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis”.

Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis

Cell(2021)10.1016/j.cell.2021.01.022

N/A

0.897DataRank · unranked

394 citations

Orr Ashenberg, Itay Tirosh, Simon Gritsch, Elizabeth M. Perez, Sascha Marx +38 more

Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2291

N/A

0DataRank · unranked

175 citations

Prafulla C. Gokhale, Maria C. Speranza, Benjamin K. Eschle, Michael J. Poitras, Margaret K. Wilkens +18 more

Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity

Cancer Discovery(2021)10.1158/2159-8290.cd-20-0913

N/A

0DataRank · unranked

219 citations

Erik H. Knelson, Jacquelyn O. Wolff, Amir Vajdi, Maria Saigí, Marco Campisi +38 more

An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer

Nature Cancer(2022)10.1038/s43018-022-00351-8

N/A

0DataRank · unranked

163 citations

Tyler S. Beyett, Jaebong Jang, William W. Feng, Magda Bahcall, Heidi M. Haikala +21 more

A Novel HER2-Selective Kinase Inhibitor Is Effective in HER2 Mutant and Amplified Non–Small Cell Lung Cancer

Cancer Research(2022)10.1158/0008-5472.can-21-2693

N/A

0DataRank · unranked

36 citations

Jaebong Jang, Tyler S. Beyett, Yoonji Eum, Heidi M. Haikala, Alyssa Verano +13 more

Aurora A kinase inhibition induces accumulation of SCLC tumor cells in mitosis with restored interferon signaling to increase response to PD-L1

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101282

N/A

0DataRank · unranked

25 citations

Navin R. Mahadevan, Leslie Duplaquet, Deli Hong, Yavuz T. Durmaz, Kristen L. Jones +17 more